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STUDIES OF HEMOSTASIS IN THE EHLEItS-DANLOS SYNDROME*
PAUL G. FRICK, M.D., PH.D.f AND JOHN D. KRAFCHUK, M.D4
Ehiers-Danlos syndrome is a congenital hereditary dystrophic abnormality
characterized by (a) fragility of the skin and blood vessels, (b) hyperelasticity
of the skin, and (c) hypermobility of the joints, showing additionally at times,
pseudotumors over bony prominences, calcified subcutaneous nodules, and
skeletal anomalies. Easy bruising of the skin with the formation of hematomas
represents one of the more frequent and important manifestations of the syn-
drome, and may bring the patient to the attention of a hematologist before he is
seen by a dermatologist. However, studies of the hemostatic mechanism in this
unusual condition are incomplete and inconclusive. Rossi and Angst (1) found no
abnormalities of bleeding time, clotting time, prothrombin time, or Rumpel-
Leede test. The second case of Ronchese (2) also had a normal bleeding and
clotting time. Samuels et al. (3) and Pascher et at. (4) report cases showing posi-
tive tourniquet tests. Smith et at. (5) are the only authors who report a prolonged
clotting time, found in one patient. Benjamin and Weiner (6) report two children
with this diagnosis, in whom the bleeding time, clotting time, clot retraction,
and platelet counts were normal. A "test of capillary resistance", method not
described, was done on one patient and found positive. Kanof (7) indicates, in
reviewing the chemical and laboratory findings of this syndrome, a number of
similarities to hyperadrenocorticism in which capillary fragility is also present.
He also points out that low vitamin C levels have been reported in attempting
to explain the vascular fragility. Laane (8) reports an instance of Cushing's
syndrome and Ehlers-Danlos syndrome in the same patient, indicating fragility
of the skin and blood vessels but no laboratory data for hemostasis.
It was therefore considered of interest to more fully investigate the hemostatic
mechanisms in this syndrome with newer technics available, attempting to
elucidate pathogenetic factors in relation to other manifestations of the condi-
tion.
MATERIALS AND METHODS
Bleeding time: Method of Ivy (9).
Clotting time of venous blood: One millimeter of blood was placed in each of
two glass tubes (75 by 8 imn.). Starting ten minutes after venipuncture, the
first tube was tilted every minute until clotted. Tilting of the second tube was
started when the endpoint of the first was reached. The endpoint of the second
tube was recorded as the clotting time of venous blood.
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Prothrombin time: Method of Quick (10).
Recalcification time: The time interval was recorded between the addition of
0.1 ml. of 1/40 M CaC12 solution to 0.1 ml. of oxalated plasma and the appear-
ance of a clot.
Platelet count: Method of Rees-Ecker (11).
Capillary fragility test: Rumpel-Leede test (12). A blood pressure cuff was
applied about the upper arm and kept inflated at a pressure half way between
systolic and diastolic blood pressure for 5 minutes. The appearance of more than
10 petechiae in a circle of 5 cm. in diameter of the volar surface of the forearm
was considered a positive test.
Clot retraction: The clot was observed after incubation at 37°C for 12 hours.
Fibrinogen determination: Method of Ratnoff (13).
Thrombin time: The time interval was recorded between the addition of 0.1
ml. of a standardized thrombin solution to 0.1 ml. of oxalated plasma and the
appearance of a clot.
Prothrombin consumption test: 2.0 ml. of blood were placed in a dry glass tube
(75 by 8 mm.) and incubated at 37°C. Two hours later, 0.1 ml. of the super-
natant serum was added to a mixture of 0.1 ml. of normal BaSO4 treated plasma
(representing fibrinogen substrate), 0.1 ml. of thromboplastin solution, and 0.1
ml. of 1/40 M CaCl2 solution. The time interval between the addition of serum
and the appearance of a clot yielded the figure for serum prothrombin time. To
prepare the normal BaSO4 treated plasma, 100 mgms. of BaSO4 was added for
each milliliter of a normal oxalated plasma specimen. The mixture was gently
shaken at room temperature for 5 minutes, and the BaSO4 then centrifuged out
at 200 r.p.m. for 10 minutes.
The normal values for these tests of hemostasis at the laboratory where the
work was carried out are listed in table 1.
RESULTS
Comprehensive studies of hemostasis were carried out on three patients and
other members of the families of two of these. Two of the patients were boys,
TABLE 1
,Studies of hemostasis in three patients with Ehiers-Danlos syndrome
Test Case L. G. Case G. W. Case R. L. Normal
Bleeding time, in minutes 5 3 2 max. 6
Clotting time, in minutes 22 19 21 max. 25
Prothrombin time, in seconds 12.4 13.4 12.5 12.0—14.0
Recalcification time, in seconds 135 180 105 max. 180
Platelets per Cu. mm 170,000 212,000 228,000 150—250,000
Rumpel-Leede test positive positive positive negative
Clot retraction normal normal normal normal
Fibrinogen, mgm. per 100 ml 320 300 290 250—350
Thrombin time, in seconds 24.0 23.0 24.3 23.0—28.0
Prothrombin consumption time, in sec-
onds. (Serum prothrombin time 2 hours
after venepuncture) 28.6 27.9 29.7 above 25.0
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G. W. age 7 years, and L. G. age 9 years, who presented skin hyperelasticity,
joint hypermobility, and skin fragility with frequent poorly healing lacerations
leaving characteristic soft scars on the forehead and lower extremities. Neither
showed excessive bleeding from lacerated areas and there were no other hemor-
rhagic symptoms or hemarthrosis. The third patient, R. L., a 21 year old white
female, presented only hyperelasticity of the skin and easy bruising with hema-
toma formation. There were no other hemorrhagic symptoms, and menstrual
loss was considered normal.
The tests of hemostasis for the three patients are presented in table 1. All
results are within normal limits except for the consistently positive Rumpel-
Leede tests, which yielded results of approximately the same intensity in all
three patients. The normal consumption of prothrombin indicates normal con-
centrations of all the plasma precursors of thromboplastin: anti-hemophilic
globulin, plasma thromboplastin component, plasma thromboplastin antecedent
(14), fourth plasma component of Spaet (15), and fifth plasma component of
Ratnoff (16). The same test also established the presence of normal platelet
function. The normal prothrombin time excludes not only hypoprothrombi-
nemia, but also indicates that there is no deficiency of labile and stable prothrom-
bin conversion factors (17). The absence of any clotting inhibitors of the heparin
type is established by the normal thrombin time. Hence all known plasma clotting
factors can be considered present in normal concentrations.
Similar studies of consanguinous relatives of the two boys (G. W. and L. G.)
were also carried out. In the family of G. W., the mother, one sister, and one
brother presented normal values for the indicated hemostatic studies except
for positive Rumpel-Leede tests. Two other siblings had normal findings for the
Rumpel-Leede test. The father was not available for study. For L. G., the mother,
one sister, and one brother similarly showed, as the only abnormal finding,
positive Rumpel-Leede tests. The father and three other siblings demonstrated
no hemostatic abnormalities.
In none of these related individuals were there any overt manifestations of
the Ehlers-Danlos Syndrome, except that the mother of L. G. showed the peculiar
velvety smooth skin which has been considered a minor characteristic of the
syndrome.
DISCUSSION
A positive Rumpel-Leede test in the presence of normal platelets, qualita-
tively and quantitatively, suggests increased capillary fragility. In general, when
capillary fragility is greater than normal, a prolonged bleeding time is also
present. Since this was not found in the patients studied, other factors must be
considered. A plausible explanation is suggested by the histopathologic picture
of the skin in Ehlers-Danlos Syndrome, which reveals normal morphology for
the blood vessels, but a diminution and fragmentation of the collagen fibers in
the dermis (3, 4, 18, 19, 20, 21, 22). In normal skin, stretching and the mechani-
cal limit of tension are a function of the collagen fibers. With defective collagen
tissue, the skin stretches excessively, and lacerates easily on local trauma. The
network of collagen fibers also protects the cutaneous blood vessels against the
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effects of excessive stretching or increased intravascular pressure (as during the
Rumpel-Leede test). The development of hematomas following local trauma
and appearance of petechiae in the Rumpel-Leede test are then compatible
with the presence of a normal bleeding time. In the lancet stab wound used in
the determination of bleeding time, hemostasis is afforded by platelet agglutina-
tion and vasoconstriction. Since these mechanisms are not impaired in Ehlers-
Danlos Syndrome, the test for bleeding time is normal.
Similarly, the absence of an overt bleeding tendency despite easy bruising, is
compatible with this concept. In the presence of normal plasma clotting factors
and normal retraction of the vascular wall, bleeding occurs only when local
trauma causes disruption of unprotected cutaneous blood vessels. If the overlying
skin remains intact, hematomas are formed which are comparable to those which
occur in normal skin.
The presence of a positive Rumpel-Leede test in the mothers and siblings of
two of the patients suggests that this character of the syndrome is transmitted
as a dominant gene with various degrees of penetration. That other manifesta-
tions of the disease are hereditary has been reported by several authors (1, 21,
23, 24), whose data are in agreement with the hereditary pattern of the single
abnormal hemostatic test.
SUMMARY
Tests of hemostasis have been performed on three patients with Ehiers-Danlos
syndrome who showed easy bruising of the skin, and members of the families
of two of them. A positive Rumpel-Leede test was consistently found as the
only hemostatic abnormality. All known plasma clotting factors were present
in normal amounts and there were no qualitative or quantitative deficiencies of
platelets. The increased capillary fragility is discussed in relation to the histo-
pathological collagen abnormality found in this disease.
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